A world class team driving innovation

Megan Burger is Chief Executive Officer, drawing on deep expertise as a qualified Medical Laboratory Technologist and a strong foundation in clinical leadership. Currently completing her Master’s degree in Immunology at Stellenbosch University, Megan combines a meticulous attention to detail with hands-on experience from leading laborator

Megan Burger is Chief Executive Officer, drawing on deep expertise as a qualified Medical Laboratory Technologist and a strong foundation in clinical leadership. Currently completing her Master’s degree in Immunology at Stellenbosch University, Megan combines a meticulous attention to detail with hands-on experience from leading laboratory roles at the National Health Laboratory Service. Her vision, scientific acumen, and commitment to good laboratory practice drive the organization’s strategy and innovation in medical diagnostics.

Professor Novel N. Chegou, PhD, serves as Chief Science Officer, bringing deep expertise in tuberculosis immunology and diagnostics. As head of the ISO 15189-accredited TB Diagnostics Biomarker Research Laboratory at Stellenbosch University, he leads pioneering research into the discovery and validation of TB biomarkers, with a strong foc

Professor Novel N. Chegou, PhD, serves as Chief Science Officer, bringing deep expertise in tuberculosis immunology and diagnostics. As head of the ISO 15189-accredited TB Diagnostics Biomarker Research Laboratory at Stellenbosch University, he leads pioneering research into the discovery and validation of TB biomarkers, with a strong focus on point-of-care diagnostic development. Professor Chegou’s leadership bridges practical innovation and academic excellence, making him a driving force in advancing TB diagnosis and global health research.

Professor Gerhard Walzl is a clinician scientist and leader in tuberculosis research, serving as the Chief Medical Officer for TB Diagnostics, as well as Executive Head of the Department of Biomedical Sciences at Stellenbosch University. As founder of the Stellenbosch University Immunology Research Group (SUN-IRG), he bridges clinical and

Professor Gerhard Walzl is a clinician scientist and leader in tuberculosis research, serving as the Chief Medical Officer for TB Diagnostics, as well as Executive Head of the Department of Biomedical Sciences at Stellenbosch University. As founder of the Stellenbosch University Immunology Research Group (SUN-IRG), he bridges clinical and laboratory sciences to drive advances in TB biomarker discovery, diagnostics, and treatment response monitoring. With decades of experience in high TB prevalence settings and expertise in both infectious diseases and immunology, Professor Walzl is a visionary executive championing innovation in global health.

Fred Lutz serves as Chief Operating Officer, leveraging a strong background in operational leadership and startup growth across multiple sectors. With a Master’s in economics and expertise in both technology commercialization and applied analytics, Fred has guided teams at global ventures and led successful product launches. He holds pate

Fred Lutz serves as Chief Operating Officer, leveraging a strong background in operational leadership and startup growth across multiple sectors. With a Master’s in economics and expertise in both technology commercialization and applied analytics, Fred has guided teams at global ventures and led successful product launches. He holds patents in blockchain and risk analytics technology, and has advised startups, private companies, and government clients on operational strategy, digital transformation, and artificial intelligence. Fred’s collaborative approach ensures efficient scaling and high-impact execution for the organization’s mission.